The Vanderbilt-Ingram Cancer Center — Nashville, Tennessee

The Vanderbilt-Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

The Vanderbilt-Ingram Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Carcinoma, Small Cell, Small Cell Lung Cancer.

Sponsors: Merrimack Pharmaceuticals, Sunesis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Vanderbilt-Ingram Cancer Center?

The Vanderbilt-Ingram Cancer Center has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Vanderbilt-Ingram Cancer Center conducted?

The Vanderbilt-Ingram Cancer Center has 2 clinical trials on record. Their work covers Advanced Solid Tumors, Carcinoma, Small Cell, Small Cell Lung Cancer.

Is The Vanderbilt-Ingram Cancer Center accredited by Crixeo Clinical Trials?

The Vanderbilt-Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Vanderbilt-Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.